introduced the full‐length MYBPC3 cDNA into abnormal cardiomyocytes induced by pluripotent stem cells from HCM patients caused by mutation of the MYBPC3 gene, hence increasing the cMyBP‐C expression level and successfully improving cardiac hypertrophy. The gene discussed is MYBPC3; the disease is cardiac hypertrophy.